Literature DB >> 34145639

Autoimmune disease and oral squamous cell carcinoma: A systematic review.

Anjali Pillai1, Dauren Adilbay1, Konstantina Matsoukas2, Ian Ganly1, Snehal G Patel1.   

Abstract

BACKGROUND: Oral cancer is typically related to environmental carcinogen exposure including tobacco and alcohol. Other less investigated risk factors may be related to a suppressed or dysregulated immune state, and in oral cancer, various levels of immune dysregulation have been found to affect survival and recurrence rates. The rationale for this systematic review was to investigate the possible role that a growing chronic host condition like an autoimmune disease may play in this disease.
METHODS: A systematic search of the literature was carried out using four electronic databases in order to identify original research of any analytic study design type that investigated the relationship between autoimmune disease and oral cancer. Out of 1,947 identified records, 24 observational studies were included for qualitative synthesis.
RESULTS: The studies varied in end points ranging from overall survival (OS), standardized incidence ratio (SIR), and hazard ratio (HR). Due to the heterogenous sampling of studies even within the same study design group, a meta-analysis was not employed. The current state of the literature is varied and heterogenous in both study design and endpoints.
CONCLUSION: Major limitations existed introducing significant bias especially in determining cancer risk such as lack of information surrounding known etiologic risk factors such as alcohol and tobacco consumption. Despite these limitations, a signal was seen between autoimmune disease and oral cancer outcomes and risk. Future studies investigating the relationship between autoimmune disease and oral cancer in a more focused and quantitative manner are therefore needed.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autoimmune disease; cancer risk; immune dysregulation; oral cancer; systematic review

Mesh:

Year:  2021        PMID: 34145639      PMCID: PMC9453852          DOI: 10.1111/jop.13218

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   3.539


  43 in total

1.  Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.

Authors:  Meng-Yu Weng; Yu-Tung Huang; Ming-Fei Liu; Tsung-Hsueh Lu
Journal:  Ann Rheum Dis       Date:  2011-11-09       Impact factor: 19.103

Review 2.  HIV infection and cancer in the era of highly active antiretroviral therapy (Review).

Authors:  Giuseppe Barbaro; Giorgio Barbarini
Journal:  Oncol Rep       Date:  2007-05       Impact factor: 3.906

3.  Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis.

Authors:  Alex M Trafford; Rosa Parisi; Evangelos Kontopantelis; Christopher E M Griffiths; Darren M Ashcroft
Journal:  JAMA Dermatol       Date:  2019-12-01       Impact factor: 10.282

4.  Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.

Authors:  E H Bae; S Y Lim; K-D Han; J-Hy Jung; H S Choi; C S Kim; S K Ma; S W Kim
Journal:  Lupus       Date:  2019-02-02       Impact factor: 2.911

5.  Incidence of cancer in a cohort of patients with primary Sjögren syndrome in Argentina.

Authors:  Martin Brom; Sebastian Moyano; Ignacio J Gandino; Marina Scolnik; Enrique R Soriano
Journal:  Rheumatol Int       Date:  2019-08-30       Impact factor: 2.631

6.  Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.

Authors:  Loes H C Nissen; Lauranne A A P Derikx; Anouk M E Jacobs; Carla M van Herpen; Wietske Kievit; Rob Verhoeven; Esther van den Broek; Elise Bekers; Tim van den Heuvel; Marieke Pierik; Janette Rahamat-Langendoen; Robert P Takes; Willem J G Melchers; Iris D Nagtegaal; Frank Hoentjen
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

7.  Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.

Authors:  Livia Biancone; Alessandro Armuzzi; Maria Lia Scribano; Renata D'Inca; Fabiana Castiglione; Claudio Papi; Erika Angelucci; Marco Daperno; Filippo Mocciaro; Gabriele Riegler; Walter Fries; Gianmichele Meucci; Patrizia Alvisi; Luisa Spina; Sandro Ardizzone; Carmelina Petruzziello; Alessandra Ruffa; Anna Kohn; Maurizio Vecchi; Luisa Guidi; Roberto Di Mitri; Sara Renna; Calabrese Emma; Francesca Rogai; Alessandra Rossi; Ambrogio Orlando; Francesco Pallone
Journal:  J Crohns Colitis       Date:  2016-03-01       Impact factor: 9.071

Review 8.  Oral manifestations of autoinflammatory and autoimmune diseases.

Authors:  Špela Baglama; Katarina Trčko; Janez Rebol; Jovan Miljković
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2018-03

9.  Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.

Authors:  Sophie Bensing; Lena Brandt; Farnoush Tabaroj; Olof Sjöberg; Bo Nilsson; Anders Ekbom; Paul Blomqvist; Olle Kämpe
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-22       Impact factor: 3.478

Review 10.  The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.

Authors:  Emma J de Ruiter; Marc L Ooft; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2017-08-09       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.